Vertex Pharmaceuticals Stock Price

1.50 (0.71%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Vertex Pharmaceuticals Inc VRTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.50 0.71% 211.58 19:44:44
Close Price Low Price High Price Open Price Previous Close
211.58 209.07 213.51 212.19 210.08
Bid Price Ask Price Spread News
211.01 211.50 0.49 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
23,865 1,715,758 $ 211.62 $ 363,091,625 2,123,045 186.41 - 306.08
Last Trade Time Type Quantity Stock Price Currency
19:54:35 5 $ 211.50 USD

Vertex Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 55.11B 260.47M 260.32M $ 4.16B $ 1.89B 4.51 26.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -37.20k 0.80%

more financials information »

Vertex Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VRTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week217.79225.97208.23215.903,564,051-6.21-2.85%
1 Month264.10280.99208.23231.422,508,130-52.52-19.89%
3 Months278.8772284.85208.23250.131,661,089-67.30-24.13%
6 Months270.03306.08208.23265.911,703,860-58.45-21.65%
1 Year190.37306.08186.41246.881,661,22521.2111.14%
3 Years155.32306.08136.50198.821,463,39856.2636.22%
5 Years110.79306.0871.46157.491,572,152100.7990.97%

Vertex Pharmaceuticals Description

Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex's pipeline also includes therapies for cancer, pain, inflammatory diseases, influenza, and other rare diseases.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.